A clinical evaluation of the comparable efficacy of hyaluronic acid-based foam and ceramide-containing emulsion cream in the treatment of mild-to-moderate atopic dermatitis
- PMID: 21896129
- DOI: 10.1111/j.1473-2165.2011.00568.x
A clinical evaluation of the comparable efficacy of hyaluronic acid-based foam and ceramide-containing emulsion cream in the treatment of mild-to-moderate atopic dermatitis
Abstract
Background: A variety of prescription devices have been developed to improve barrier function in persons with atopic dermatitis. These products are based primarily on the use of occlusive agents to decrease transepidermal water loss, creating an environment for optimal healing.
Aim: A newly developed hyaluronic acid based, pH neutral foam technology formulated to maximize humectancy and normalize transepidermal waster loss was evaluated for its ability to optimize barrier function while minimizing unnecessary irritation.
Methods: This double blind split body study enrolled 20 subjects with mild to moderate symmetrical atopic dermatitis involving body surface area greater than or equal to 10% using the arms or the legs as the target site. Subjects were randomized to apply the hyaluronic acid based emollient foam or the reference ceramide-containing emulsion cream to one side of the body with the other test product applied to the opposite side. Subject and investigator ratings were made for erythema, scaling, lichenification, excoriation, itching, stinging, and burning at baseline, week 2, and week 4.
Results: Both formulations achieved statistically significant improvement in all clinical signs and symptoms of atopic dermatitis by week 4, however the hyaluronic acid foam achieved statistically significant improvement in overall eczema severity by week 2, whereas the ceramide-containing emulsion cream did not. The subject's preference statistically significantly favored the foam in terms of ability to spread, moisturize, ease of use, and lack of odor. In addition, the foam was preferred for effectiveness and ability to soothe.
Conclusion: A prescription hyaluronic acid based foam device offers an aesthetic formulation with excellent efficacy in patients requiring an environment for barrier repair with mild to moderate atopic dermatitis.
© 2011 Wiley Periodicals, Inc.
Similar articles
-
Bilateral comparison study of pimecrolimus cream 1% and a ceramide-hyaluronic acid emollient foam in the treatment of patients with atopic dermatitis.J Drugs Dermatol. 2011 Jun;10(6):666-72. J Drugs Dermatol. 2011. PMID: 21637908 Clinical Trial.
-
An over-the-counter moisturizer is as clinically effective as, and more cost-effective than, prescription barrier creams in the treatment of children with mild-to-moderate atopic dermatitis: a randomized, controlled trial.J Drugs Dermatol. 2011 May;10(5):531-7. J Drugs Dermatol. 2011. PMID: 21533301 Clinical Trial.
-
A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.J Dermatolog Treat. 2005 Aug;16(3):142-8. doi: 10.1080/09546630510033159. J Dermatolog Treat. 2005. PMID: 16096179 Clinical Trial.
-
Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis.Clin Ther. 2006 Dec;28(12):1972-82. doi: 10.1016/j.clinthera.2006.12.014. Clin Ther. 2006. PMID: 17296454 Review.
-
Patient acceptability, efficacy, and skin biophysiology of a cream and cleanser containing lipid complex with shea butter extract versus a ceramide product for eczema.Hong Kong Med J. 2015 Oct;21(5):417-25. doi: 10.12809/hkmj144472. Epub 2015 Aug 28. Hong Kong Med J. 2015. PMID: 26314567 Review.
Cited by
-
Topical treatment with SPHINGOLIPIDS and GLYCOSAMINOGLYCANS for canine atopic dermatitis.BMC Vet Res. 2020 Mar 20;16(1):92. doi: 10.1186/s12917-020-02306-6. BMC Vet Res. 2020. PMID: 32197613 Free PMC article.
-
Hyaluronic Acid Hydrogel Containing Resveratrol-Loaded Chitosan Nanoparticles as an Adjuvant in Atopic Dermatitis Treatment.J Funct Biomater. 2023 Jan 31;14(2):82. doi: 10.3390/jfb14020082. J Funct Biomater. 2023. PMID: 36826881 Free PMC article.
-
Emollients and moisturisers for eczema.Cochrane Database Syst Rev. 2017 Feb 6;2(2):CD012119. doi: 10.1002/14651858.CD012119.pub2. Cochrane Database Syst Rev. 2017. PMID: 28166390 Free PMC article.
-
Application of Xanthan Gum and Hyaluronic Acid as Dermal Foam Stabilizers.Gels. 2022 Jun 30;8(7):413. doi: 10.3390/gels8070413. Gels. 2022. PMID: 35877498 Free PMC article.
-
Unsaturated fatty acid-enriched extract from Hippophae rhamnoides seed reduces skin dryness through up-regulating aquaporins 3 and hyaluronan synthetases 2 expressions.J Cosmet Dermatol. 2021 Jan;20(1):321-329. doi: 10.1111/jocd.13482. Epub 2020 Jul 8. J Cosmet Dermatol. 2021. PMID: 32638495 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources